Past Speakers



Mr. Masaru Yoshida

Chief, Associate Professor, Division of Metabolomics Research (Chief) Division of Gastroenterology
The Integrated Center for Mass Spectrometry Kobe University Graduate School of Medicine, Japan

Session :

Trend of Japanese Functional Food Market, Research and Development

Speaker Profile :


2008-present Associate Professor, Kobe University Graduate School of Medicine

2005-2008  Assistant Professor, Kobe University Graduate School of Medicine

2004-2005  Instructor, Harvard Medical School, Boston, MA, USA

2001-2004  Research Fellow, Brigham and Women’s Hospital and Harvard Medical

School, Boston, MA, USA

2000-2001  Research Fellow in Medicine, Kyoto University, Kyoto, Japan


1992 M.D.       School of Medicine, Kobe University, ,Kobe, JAPAN

2004 Ph.D.     Graduate School of Medicine, Kyoto University, Kyoto, JAPAN


1998, the Japan Society for the Promotion of Science, Research Fellowship Award; 2000, the Tsumura Immunology Foundation, Research Fellowship Award; 2000, Hamanako Symposium, Research Award; 2001, Japan Foundation of Aging and Health, Research Award; 2001, the Japan Society for the Promotion of Science, Research Award; 2003, Crohn's & Colitis Foundation of America, Research Fellowship Award; 2003, Brigham and Women's Hospital, Poster of Distinction Award; 2004, GRG/AGA, Fellow Travel Award


REFERENCE (selected out of 113 peer-reviewed papers.)

1. Nishiumi S, et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics. 2010 Nov;6(4):518-28.,

2. Kawano Y, et al. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport. Arch Biochem Biophys. 2010 Dec 15;504(2):221-7.,

3. Shiomi Y, et al. A GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis. 2011 Nov;17(11):2261-74.,

4. Hori S, et al. A metabolomic approach to detect early stages of lung cancers. Lung Cancer. 2011 Nov;74(2):284-92,

5. Ooi M, et al. The GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis. Inflamation Res. 2011 Sep;60(9):831-40.,

6. Tsugawa H, et al. Practical non-targeted gas chromatography/mass spectrometry-based metabolomics platform for metabolic phenotype analysis. J Biosci Bioeng. 2011 Sep;112(3):292-8.,

7. Kondo Y, et al. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry. Biomark Med. 2011 Aug;5(4):451-60.,

8. Ikeda A, et al. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomedical Chromatography. (in press),

9. Yoshida M, et al. Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry. J Gastroenterol. 2012 Jan;47(1):9-20.,

10. Matsubara A, et al. Highly sensitive and rapid profiling method for carotenoids and their epoxidized products using supercritical fluid chromatography coupled with electrospray ionization-triple quadrupole mass spectrometry. J Biosci Bioeng. 2012 Jun;113(6):782-7.,

11. Yoshie T, et al. Regulation of the metabolite profile by an APC gene mutation in colorectal cancer. Cancer Sci. 2012 Jun;103(6):1010-21.,

12. Sakai A, et al. Metabolomic analysis to discover candidate therapeutic agents against acute pancreatitis. Arch Biochem Biophys. 2012 Jun 15;522(2):107-20.,

13. Hasokawa M, et al., Identification of Biomarkers of Stent Restenosis With Serum Metabolomic Profiling Using Gas Chromatography/Mass Spectrometry. Circ J. 2012;76(8):1864-73

14. Uchikata T, et al. Development of oxidized phosphatidylcholine isomer profiling method using supercritical fluid chromatography/tandem mass spectrometry. J Chromatogr A. 2012 Aug 10;1250:205-11.

15. Nishiumi S, et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS ONE 2012;7(7):e40459. 





  Download Center